Notably, in humans, alterations in glucose metabolism—manifested by elevated blood glucose levels, reduced insulin sensitivity, and compensatory hyperinsulinemia—can be observed up to 13 years prior to the clinical diagnosis of T2DM [21]. This evidence concerns the gene INS and hyperinsulinism.